Ascentage Pharma Group International

HKEX:6855.HK

38.8 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 1,069.2961,492.241,743.8211,024.4882.457957.08814.821294.529
Short Term Investments 6.55711.9054.1453.0262.59914.399384.168157.39
Cash and Short Term Investments 1,069.2961,504.1451,747.9661,027.426885.056971.487398.989451.919
Net Receivables 145.89354.35653.96800000.556
Inventory 16.1679.4483.930000-157.39
Other Current Assets 81.72868.53979.41651.61824.0496.42115.72411.78
Total Current Assets 1,344.1781,636.4881,885.281,079.044909.105990.219414.713463.699
Non-Current Assets:
Property, Plant & Equipment, Net 957.232648.722844.368477.001142.28733.99225.334.513
Goodwill 24.69424.69424.69424.69424.69424.69424.69424.694
Intangible Assets 85.44684.30460.41166.40572.192108.52880.70987.129
Goodwill and Intangible Assets 110.14108.99885.10591.09996.886133.222105.403111.823
Long Term Investments 18.94918.53127.84531.77432.19145.119-353.84-144.839
Tax Assets 59.84254.29451.64800000
Other Non-Current Assets 10.052-54.294-51.648-599.874-271.36426.824390.058158.145
Total Non-Current Assets 1,156.215776.251957.318599.874271.364239.157166.951129.642
Total Assets 2,500.3932,830.2612,940.061,731.0391,205.051,229.376581.664593.341
Liabilities & Equity:
Current Liabilities:
Account Payables 72.44595.55970.86123.36113.0845.0813.8220.156
Short Term Debt 616.404518.38349.45150.56192.19437.5872.0190.358
Tax Payables 8.3897.1793.2795.9841.61.0040.570.137
Deferred Revenue 0-518.383-49.451-50.561-92.194000
Other Current Liabilities 245.324785.593290.248252.787188.97862.60173.69477.104
Total Current Liabilities 934.173881.152361.109276.148202.062105.26979.53577.618
Non-Current Liabilities:
Long Term Debt 1,179.1911,265.21,026.592473.0559.2114.4572.8790.472
Deferred Revenue Non-Current 287.549218.625243.27940.20735.09727.03215.968.737
Deferred Tax Liabilities Non-Current 10.54912.15113.75315.35516.95718.55920.16121.763
Other Non-Current Liabilities 18.299-230.776-257.032-55.56251.2482,085.645594.926499.357
Total Non-Current Liabilities 1,495.5881,265.21,026.592473.055112.5132,135.693633.926530.329
Total Liabilities 2,429.7612,421.6031,705.323884.418314.5752,240.962713.461607.947
Equity:
Preferred Stock 504.461518.514550.949509.812467.503615.81700
Common Stock 0.1970.180.1780.1540.1420.06300
Retained Earnings -5,365.122-4,439.485-3,556.561-2,774.137-2,096.531-615.817-270.51-151.996
Accumulated Other Comprehensive Income/Loss -504.461-518.514-550.949-509.812-467.503-14.757-7.183-3.354
Other Total Stockholders Equity 5,425.3424,847.9634,791.123,620.6042,986.864-996.892145.896140.744
Total Shareholders Equity 60.417408.6581,234.737846.621890.475-1,011.586-131.797-14.606
Total Equity 70.632408.6581,234.737846.621890.475-1,011.586-131.797-14.606
Total Liabilities & Shareholders Equity 2,500.3932,830.2612,940.061,731.0391,205.051,229.376581.664593.341